This might be related to the more severe amyloid and tau pathologies in AD compared to DLB and PD, or it is possible that α-synuclein pathology in some way affects the association between sAPPα and sAPPβ with the development of AD pathology. This evidence concerns the gene MAPT and Alzheimer disease.